Press Resease

Obesity Surgery Devices Market By Device Type (Adjustable Gastric Bands, Clip Appliers, Intragastric Balloons, Surgical Staples, And Others) For Gastric Bypass Surgery, Sleeve Gastrectomy Surgery, And Other End User - Global Industry Perspective, Comprehensive Analysis And Forecast, 2020 – 2028

Published Date: 05-Jul-2021 Category: Medical Device Report Format : PDF Pages: 145 Report Code: ZMR-2010 Status : Published

The global Obesity Surgery Devices market accounted for USD 2.43 Billion in 2020 and is expected to reach USD 4.02 Billion by 2028, growing at a CAGR of around 6.2% between 2021 and 2028.

Description

Market Overview     

The global  Obesity Surgery Devices market accounted for USD 2.43 Billion in 2020 and is expected to reach USD 4.02 Billion by 2028, growing at a CAGR of around 6.2% between 2021 and 2028.   

The global obesity surgery devices market is majorly boosted by the increasing prevalence of obesity everywhere in the world. Other major boosting factors of the obesity surgery devices market are growing awareness about obesity-associated complexities and the rising occurrence of obesity-related chronic diseases. On the opposite hand, lower disposable revenues and therefore the high price of surgeries are the main limitation which may hinder the event of the obesity surgery devices market.

Nevertheless, government initiatives to prevent obesity paired with an enormous investment in obesity surgery devices everywhere on the planet are expected to reveal new growth opportunities within the near future for the obesity surgery devices market. Rising initiatives by market players are additionally one among the explanations that are liable for the development of the obesity surgery devices market. for instance, in April 2018, MID arranged for XXIIIrd World Congress IFSO International Federation for the surgery of metabolic & obesity disorders, thus powering the obesity surgery devices market.

COVID-19 Impact Analysis  

Besides, the COVID-19 outbreak, there's a drastic rise in the demand for medical facilities across the world. The increasing corona cases across the world are forcing governments of developed and emerging countries to extend their patient handling and increase surgery capacities which have been delayed due to pandemics. Several governments are proposing obesity awareness initiatives and taking various action plans to curb obesity. Governments also are encouraging non-invasive obesity surgeries to stop infection cases.

Growth Factors

The global Obesity Surgery Devices market is propelled owing to the increasing obesity among children and adults everywhere in the world which has become a significant health issue. Also, adults are more apt to numerous persistent diseases. This remains a key factor fueling the demand for obesity surgery devices within the global market. Rising inclination towards a sedentary lifestyle and burgeoning frequency of consuming food is the foremost likely to spice up obesity, and eventually the marketplace for obesity surgery devices. Increasing awareness among overweight people in developing regions about the potential ill effects of obesity, including diabetes, CVDs, and stroke is predicted to drive the obesity surgery devices market. Also, the increasing availability of surgical treatments for reducing excess weight is additionally anticipated to support the market growth.

Report Scope:  

Segment Analysis Preview  

The obesity surgery devices market is divided based on various surgical procedures like sleeve gastrectomy surgery, gastric bypass surgery, and others including gastric banding surgery. The gastric bypass surgery sector in the obesity surgery devices market holds utmost share and can keep it up to try to so within the coming years. Whereas, sleeve gastrectomy is foreseen to witness the fastest growth during the forecast period 2021-2028. Based on device type, the obesity surgery devices market is bifurcated into intragastric balloons, adjustable gastric bands, surgical staples, clip appliers, and others including trocars.

Regional Analysis Preview

North America is probably going to remain the leading area within the obesity surgery devices market followed by Europe over the forecast period. Requirement for obesity surgery devices was uppermost in North America particularly within the U.S. Asia Pacific is probably going to be the reasonable developing area during the forecast period in the obesity surgery devices market. Furthermore, Latin America and therefore the MEA also are likely to point out reasonable development for the obesity surgery devices market within the coming years.

Key Market Players & Competitive Landscape

The major players that are comprised in the Obesity Surgery Devices market are Medtronic, Inc., Allergan, Inc., Cousin Biotech, EnteroMedics, Inc., Mediflex Surgical Products, Johnson & Johnson, Aspire Bariatrics, TransEnterix Inc., and Spatz FGIA Inc. among others. These players are set to bolster the development of obesity surgery devices market.

The global  Obesity Surgery Devices Market is segmented as follows:

By Device Type

  • Adjustable Gastric Bands
  • Intragastric Balloons
  • Clip Appliers
  • Surgical Staples
  • Trocars
  • Others

By Surgery Procedure

  • Gastric Bypass Surgery
  • Sleeve Gastrectomy Surgery
  • Gastric Banding Surgery
  • Others

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter No. 1 Introduction
    • 1.1. Report Description
      • 1.1.1. Purpose of the Report
      • 1.1.2. USP & Key Offerings
    • 1.2. Key Benefits for Stakehulders
    • 1.3. Target Audience
    • 1.4. Report Scope
  • Chapter No. 2 Executive Summary
    • 2.1. Key Findings
      • 2.1.1. Top Investment Pockets
        • 2.1.1.1. Market Attractiveness Analysis, By Device Type
        • 2.1.1.2. Market Attractiveness Analysis, By Surgery Procedure
        • 2.1.1.3. Market Attractiveness Analysis, By Region
    • 2.2. Market Snapshot
    • 2.3. Global Obesity Surgery Devices Market, 2016 – 2028 (USD Billion)
    • 2.4. Insights from Primary Respondents
  • Chapter No. 3 COVID 19 Impact Analysis
    • 3.1. Impact Assessment of COVID-19 Pandemic, By Region
      • 3.1.1. North America
      • 3.1.2. Europe
      • 3.1.3. Asia Pacific
      • 3.1.4. Latin America
      • 3.1.5. The Middle-East and Africa
    • 3.2. Quarterly Market Revenue and Forecast by Region 2020 & 2021
    • 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Billion)
    • 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Billion)
    • 3.5. Key Strategies Undertaken by Companies to Tackle COVID-19
      • 3.5.1. Company Quarterly Revenue Analysis, 2019 & 2020
    • 3.6. Short Term Dynamics
    • 3.7. Long Term Dynamics
  • Chapter No. 4 Obesity Surgery Devices Market – Device Type Segment Analysis
    • 4.1. Overview
      • 4.1.1. Market Revenue Share, By Device Type, 2020 & 2028
    • 4.2. Adjustable Gastric Bands
      • 4.2.1. Market Size and Forecast, By Region (USD Billion)
      • 4.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.3. Intragastric Balloons
      • 4.3.1. Market Size and Forecast, By Region (USD Billion)
      • 4.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.4. Clip Appliers
      • 4.4.1. Market Size and Forecast, By Region (USD Billion)
      • 4.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.5. Surgical Staples
      • 4.5.1. Market Size and Forecast, By Region (USD Billion)
      • 4.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.5.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.6. Trocars
      • 4.6.1. Market Size and Forecast, By Region (USD Billion)
      • 4.6.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.6.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.7. Others
      • 4.7.1. Market Size and Forecast, By Region (USD Billion)
      • 4.7.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.7.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 5 Obesity Surgery Devices Market – Surgery Procedure Segment Analysis
    • 5.1. Overview
      • 5.1.1. Market Revenue Share, By Surgery Procedure, 2020 & 2028
    • 5.2. Gastric Bypass Surgery
      • 5.2.1. Market Size and Forecast, By Region (USD Billion)
      • 5.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.3. Sleeve Gastrectomy Surgery
      • 5.3.1. Market Size and Forecast, By Region (USD Billion)
      • 5.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.4 Gastric Banding Surgery
      • 5.4.1. Market Size and Forecast, By Region (USD Billion)
      • 5.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.5. Others
      • 5.5.1. Market Size and Forecast, By Region (USD Billion)
      • 5.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.5.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 6 Plant Factory Grow Market – Region Segment Analysis
    • 6.1. Overview
      • 6.1.1. Global Market Revenue Share, By Region, 2020 & 2028
      • 6.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD Billion)
    • 6.2. North America
      • 6.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.2.2. North America Market Revenue, By Device Type, 2016 – 2028
      • 6.2.3. North America Market Revenue, By Surgery Procedure, 2016 – 2028
      • 6.2.5. U.S.
        • 6.2.5.1. U.S. Market Revenue, By Device Type, 2016 – 2028
        • 6.2.5.2. U.S. Market Revenue, By Surgery Procedure, 2016 – 2028
      • 6.2.6. Canada
        • 6.2.6.1. Canada Market Revenue, By Device Type, 2016 – 2028
        • 6.2.6.2. Canada Market Revenue, By Surgery Procedure, 2016 – 2028
      • 6.2.7. Mexico
        • 6.2.7.1. Mexico Market Revenue, By Device Type, 2016 – 2028
        • 6.2.7.2. Mexico Market Revenue, By Surgery Procedure, 2016 – 2028
    • 6.3. Europe
      • 6.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.3.2. Europe Market Revenue, By Device Type, 2016 – 2028
      • 6.3.3. Europe Market Revenue, By Surgery Procedure, 2016 – 2028
      • 6.3.5. Germany
        • 6.3.5.1. Germany Market Revenue, By Device Type, 2016 – 2028
        • 6.3.5.2. Germany Market Revenue, By Surgery Procedure, 2016 – 2028
      • 6.3.6. France
        • 6.3.6.1. France Market Revenue, By Device Type, 2016 – 2028
        • 6.3.6.2. France Market Revenue, By Surgery Procedure, 2016 – 2028
      • 6.3.7. U.K.
        • 6.3.7.1. U.K. Market Revenue, By Device Type, 2016 – 2028
        • 6.3.7.2. U.K. Market Revenue, By Surgery Procedure, 2016 – 2028
      • 6.3.8. Italy
        • 6.3.8.1. Italy Market Revenue, By Device Type, 2016 – 2028
        • 6.3.8.2. Italy Market Revenue, By Surgery Procedure, 2016 – 2028
      • 6.3.9. Spain
        • 6.3.9.1. Spain Market Revenue, By Device Type, 2016 – 2028
        • 6.3.9.2. Spain Market Revenue, By Surgery Procedure, 2016 – 2028
      • 6.3.10. Rest of Europe
        • 6.3.10.1. Rest of Europe Market Revenue, By Device Type, 2016 – 2028
        • 6.3.10.2. Rest of Europe Market Revenue, By Surgery Procedure, 2016 – 2028
    • 6.4. Asia Pacific
      • 6.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.4.2. Asia Pacific Market Revenue, By Device Type, 2016 – 2028
      • 6.4.3. Asia Pacific Market Revenue, By Surgery Procedure, 2016 – 2028
      • 6.4.5. China
        • 6.4.5.1. China Market Revenue, By Device Type, 2016 – 2028
        • 6.4.5.2. China Market Revenue, By Surgery Procedure, 2016 – 2028
      • 6.4.6. Japan
        • 6.4.6.1. Japan Market Revenue, By Device Type, 2016 – 2028
        • 6.4.6.2. Japan Market Revenue, By Surgery Procedure, 2016 – 2028
      • 6.4.7. India
        • 6.4.7.1. India Market Revenue, By Device Type, 2016 – 2028
        • 6.4.7.2. India Market Revenue, By Surgery Procedure, 2016 – 2028
      • 6.4.8. South Korea
        • 6.4.8.1. South Korea Market Revenue, By Device Type, 2016 – 2028
        • 6.4.8.2. South Korea Market Revenue, By Surgery Procedure, 2016 – 2028
      • 6.4.9. South-East Asia
        • 6.4.9.1. South-East Asia Market Revenue, By Device Type, 2016 – 2028
        • 6.4.9.2. South-East Asia Market Revenue, By Surgery Procedure, 2016 – 2028
      • 6.4.10. Rest of Asia Pacific
        • 6.4.10.1. Rest of Asia Pacific Market Revenue, By Device Type, 2016 – 2028
        • 6.4.10.2. Rest of Asia Pacific Market Revenue, By Surgery Procedure, 2016 – 2028
    • 6.5. Latin America
      • 6.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.5.2. Latin America Market Revenue, By Device Type, 2016 – 2028
      • 6.5.3. Latin America Market Revenue, By Surgery Procedure, 2016 – 2028
      • 6.5.5. Brazil
        • 6.5.5.1. Brazil Market Revenue, By Device Type, 2016 – 2028
        • 6.5.5.2. Brazil Market Revenue, By Surgery Procedure, 2016 – 2028
      • 6.5.6. Argentina
        • 6.5.6.1. Argentina Market Revenue, By Device Type, 2016 – 2028
        • 6.5.6.2. Argentina Market Revenue, By Surgery Procedure, 2016 – 2028
      • 6.5.7. Rest of Latin America
        • 6.5.7.1. Rest of Latin America Market Revenue, By Device Type, 2016 – 2028
        • 6.5.7.2. Rest of Latin America Market Revenue, By Surgery Procedure, 2016 – 2028
    • 6.6. The Middle-East and Africa
      • 6.6.1. The Middle-East and Africa Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.6.2. The Middle-East and Africa Market Revenue, By Device Type, 2016 – 2028
      • 6.6.3. The Middle-East and Africa Market Revenue, By Surgery Procedure, 2016 – 2028
      • 6.6.5. GCC Countries
        • 6.6.5.1. GCC Countries Market Revenue, By Device Type, 2016 – 2028
        • 6.6.5.2. GCC Countries Market Revenue, By Surgery Procedure, 2016 – 2028
      • 6.6.6. South Africa
        • 6.6.6.1. South Africa Market Revenue, By Device Type, 2016 – 2028
        • 6.6.6.2. South Africa Market Revenue, By Surgery Procedure, 2016 – 2028
      • 6.6.7. Rest of Middle-East Africa
        • 6.6.7.1. Rest of Middle-East Africa Market Revenue, By Device Type, 2016 – 2028
        • 6.6.7.2. Rest of Middle-East Africa Market Revenue, By Surgery Procedure, 2016 – 2028
  • Chapter No. 7: Obesity Surgery Devices Market – Industry Analysis
    • 7.1. Introduction
    • 7.2. Market Drivers
      • 7.2.1. Driving Factor 1 Analysis
      • 7.2.2. Driving Factor 2 Analysis
    • 7.3. Market Restraints
      • 7.3.1. Restraining Factor Analysis
    • 7.4. Market Opportunities
      • 7.4.1. Market Opportunity Analysis
    • 7.5. Porter’s Five Forces Analysis
    • 7.6. PEST Analysis
    • 7.7. Regulatory Landscape
    • 7.8. By Surgery Procedure Landscape
    • 7.9. Regional Market Trends
      • 7.9.1. North America
      • 7.9.2. Europe
      • 7.9.3. Asia Pacific
      • 7.9.4. Latin America
      • 7.9.5. The Middle-East and Africa
    • 7.10. Pricing Analysis
    • 7.11. Value Chain Analysis
    • 7.12. Downstream Buyers
    • 7.13. Distributors/Traders List
  • Chapter No. 8: Competitive Landscape
    • 8.1. Company Market Share Analysis – 2019
      • 8.1.1. Global Obesity Surgery Devices Market: Company Market Share, 2019
      • 8.1.2. Global Obesity Surgery Devices Market, Company Market Revenue, 2016 – 2019 (USD Billion)
      • 8.1.3. Global Obesity Surgery Devices Market, Company Y-o-Y Growth, 2017 – 2019 (%)
      • 8.1.4. Global Obesity Surgery Devices Market: Radar Determinant Chart, 2019
    • 8.2. Strategic Developments
      • 8.2.1. Acquisitions & Mergers
      • 8.2.2. New Product Launch
      • 8.2.3. Regional Expansion
    • 8.3. Company Strategic Developments – Heat Map Analysis
  • Chapter No. 9: Company Profiles
    • 9.1. Allergan, Inc.
      • 9.1.1. Company Overview
      • 9.1.2. Key Executives
      • 9.1.3. Product Portfulio
      • 9.1.4. Financial Overview
      • 9.1.5. Operating Business Segments
      • 9.1.6. Business Performance
      • 9.1.7. Recent Developments
    • 9.2. Medtronic, Inc.
    • 9.3. EnteroMedics, Inc.
    • 9.4. Cousin Biotech
    • 9.5. Johnson & Johnson
    • 9.6. Mediflex Surgical Products
    • 9.7. TransEnterix Inc.
    • 9.8. Aspire Bariatrics
    • 9.9. Spatz FGIA Inc.
    • 9.10 Others
  • Chapter No. 10: Marketing Strategy Analysis
    • 10.1. Marketing Channel
    • 10.2. Direct Marketing
    • 10.3. Indirect Marketing
    • 10.4. Marketing Channel Development Trends
    • 10.5. Economic/Pulitical Environmental Change
  • Chapter No. 11: Research Methodulogy
    • 11.1. Research Methodulogy
    • 11.2. Phase I - Secondary Research
    • 11.3. Phase II - Data Modeling
      • 11.3.1. Company Share Analysis Model
      • 11.3.2. Revenue Based Modeling
    • 11.4. Phase III - Primary Research
    • 11.5. Research Limitations
      • 11.5.1. Assumptions

Methodology

This report is based on in-depth qualitative and quantitative analyses of the global Obesity Surgery Devices market. Zion Research has collected and analyzed key data belong to the global Obesity Surgery Devices market using a variety of methods. Quantitative analysis has been done following various projection and sampling techniques.

The qualitative analysis involved primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes were validated through experts' opinions. The market dynamics have been determined after conducting a detailed study of the micro and macroeconomic indicators of the market.

Various parameters have been taken into account, while estimating market size. The revenue generated by the leading industry participants in from the sales of Obesity Surgery Devices across the world has been calculated through primary and secondary research.

Zion Research employs the combination of secondary research followed by extensive primary research. Under secondary research, we refer to prominent paid as well as open access data sources including product literature, company annual reports, government publications, press releases, industry association’s magazines and other relevant sources for data collection. Other prominent secondary sources include STATISTA, trade journals, trade associations, statistical data from government websites, etc. 

For this study, Zion Research has conducted all-encompassing primary research with key industry participants to collect first had data. Moreover, in-depth interviews with key opinion leaders also assisted in validation of findings from secondary research and to understand key trends in the Obesity Surgery Devices industry. Primary research makes up the major source of data collection and validation.   

Primary Research

We conduct primary interviews with industry participants and commentators on an ongoing basis to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides firsthand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening the secondary research findings
  • Further, develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies

Participants who typically participate in such a process include, but are not limited to:

  • Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers and national sales managers
  • Purchasing managers, technical personnel, distributors and resellers
  • Outside experts: Investment bankers, valuation experts and research analysts specializing in specific markets

Key opinion leaders specializing in different areas corresponding to different industry verticals

Secondary Research

Secondary research sources that are typically referred to include, but are not limited to:

  • Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
  • IDC and other relevant magazines
  • Internal and external proprietary databases, and relevant patent and regulatory databases
  • National government documents, statistical databases and market reports

News articles, press releases and webcasts specific to companies operating in the market

Following a comprehensive secondary and primary research and insights thus gathered, analysts at Zion Research have provided an in-depth analysis of various aspects of the Obesity Surgery Devices market.

Models

Where no hard data is available, we use models and estimates to produce comprehensive data sets. A rigorous methodology is adopted, wherein the available hard data is cross-referenced with the following data types to produce estimates:

  • Demographic data: Population split by segments
  • Macroeconomic indicators: GDP, PPP, Per Capita Income, etc.
  • Industry indicators: Expenditure, technology stage and infrastructure, sector growth and facilities
  • Data is then cross-checked by an expert panel.

Free Analysis

Obesity is a medical condition in which excess fat is accumulated in the body. This accumulation of fat may have a negative impact on health. Obesity is associated with complex disorders such as diabetes, cardiovascular diseases, osteoarthritis and a certain type of cancer etc. Obesity is combined results of food overtake, lack of physical activity or a sedentary lifestyle and genetic factors. People with body mass index (BMI) greater than 30Kg/m2 are generally considered obese. Obesity is one of the leading preventable causes of death. Changes in diet and daily physical exercise help in treating obesity.

As per World Health Organization, worldwide obesity has nearly doubled since 1980.  In 2008, more than 1.4 billion adults, 20 and older, were overweight. Of these over 200 million men and nearly 300 million women were obese. 35% of adults aged 20 and over were overweight in 2008, and 11% were obese. 65% of the world’s population lives in countries where overweight and obesity kills more people than underweight. Overweight and obesity are the fifth leading risk for global deaths. At least 2.8 million adults die each year as a result of being overweight or obese. 44% of the diabetes burden, 23% of the ischemic heart disease burden and between 7% and 41% of certain cancer burdens are attributable to overweight and obesity. More than 40 million children under the age of five were overweight in 2011. Obesity is preventable.

Increasing prevalence of obesity across the globe is expected to be the major driver for the global obesity surgery devices market. In addition, increasing the prevalence of obesity associated chronic diseases coupled with increasing awareness about obesity associated chronic diseases among adults is expected to trigger the growth of global obesity surgery devices industry in the coming years. However, the high cost of surgeries coupled with lower disposable incomes may pose the challenge to obesity surgery devices market. Nevertheless, obesity related disorders pose risk to the health and thus demand obesity surgery devices products coupled with a huge investment in obesity surgery devices across the globe are expected to act as an opportunity for obesity surgery devices market in near future.

Based on surgery procedure, obesity surgery devices market has been segmented into gastric bypass surgery, sleeve gastrectomy surgery, gastric banding surgery, and others. Gastric bypass surgery segment holds a maximum share of global obesity surgery devices market.

Based on device type, obesity surgery devices market is classified into adjustable gastric bands, intragastric balloons, clip appliers, surgical staples, trocars and others.

North America is expected to remain the dominant region over the forecast period. Increasing obese population base and increasing awareness are expected to boost the market in this region. Europe was the second largest market followed by Asia Pacific. Asia Pacific is expected to show fastest growth rate during the forecast period while Latin America market is projected to grow at a moderate rate during the forecast period. The Middle East and Africa are also expected to experience noticeable growth in the years to come.

Some of the key players in obesity surgery devices market include Allergan, Inc., Medtronic, Inc., EnteroMedics, Inc., Cousin Biotech, Johnson & Johnson, Mediflex Surgical Products, TransEnterix Inc., Aspire Bariatrics and Spatz FGIA Inc. among others.


Frequently Asked Questions

The global  Obesity Surgery Devices Market was valued at USD 2.43 billion in 2020.

The global  Obesity Surgery Devices Market is expected to reach USD 4.02 billion by 2028, growing at a CAGR of 6.2% between 2021 to 2028.

Factors such as the increasing incidence of obesity, growth in the elderly population, healthcare infrastructure improvements, and the increasing prevalence of chronic diseases are the major factors driving the market growth.

North America in 2020 ruled the  Obesity Surgery Devices market and was believed to be the highest income-generating area all over the globe.  

The major players that are comprised in Obesity Surgery Devices market are Medtronic, Inc., Allergan, Inc., Cousin Biotech, EnteroMedics, Inc., Mediflex Surgical Products, Johnson & Johnson, Aspire Bariatrics, TransEnterix Inc., and Spatz FGIA Inc. among others.
}